Étiqueté : EU
Biosimilar medicines – Multistakeholder Event
The objective of the multistakeholder event will be to raise awareness towards all and highlight the potential of biosimilars in improving affordability and access to medicines. Read the news published by EC Directorate-General for Health...
Representatives of Patients’ Associations and Clinicians: Reopening of the Call for expressions of interest for the EMA Committee for Advanced Therapies(EMA CAT)
The Commission is re-opening the selection procedure to appoint the Representatives of Patients’ Associations and Clinicians in the Committee for Advanced Therapies of the European Medicines Agency, originally launched on 12 August 2024.The reopening is...
HTACG – Subgroup for the Identification of Emerging Health Technologies
The European Commission, Directorate General for Health and Food Safety Digital, EU4Health and Health Technology Assessment Coordination Group held a meeting for identification of emerging health technologies on November 15, 2024. Read the news announcement published...
Register now to participate onsite or online to the EU Health Policy Platform Annual Meeting on 26 November and interact with the speakers
The EU Health Policy Platform Annual Meeting will take place as a hybrid event on 26 November from 9.30 to 16.00 CET. This meeting will serve as a space for discussion among health stakeholders, starting...
Is the EU Health Policy Platform right for you? Find out, by taking a quick look at this one-page infographic now available in all EU official languages
This infographic, now available in all 24 official EU languages, explains the main features of the Health Policy Platform and how to become a Platform member. It describes the many benefits the EU Health Policy Platform...
EU4Health call for tenders: support to stakeholders on secondary use of data within the European Health Data Space
This call for tenders aims at supporting key stakeholders to comply with the European Health Data Space (EHDS) requirements and technical specifications, while supporting their collaboration in the rollout and operations of HealthData@EU. Additionally, this...
Public consultation: Implementing Regulation on joint scientific consultations on medical devices and in vitro diagnostic medical devices at Union level
Today, the European Commission launched an online public consultation on the draft implementing act on joint scientific consultations on medical devices and in vitro diagnostic medical devices at Union level under the Health Technology Assessment Regulation....
Implementation of the Hospital Exemption in the EU and its role in boosting innovation and patient access to innovative therapies
HaDEA/DG Health and Food Safety are delighted to invite you to join online the full-day event on the “Implementation of the Hospital Exemption in the EU and its role in boosting innovation and patient access...
The EU HTA Regulation: Webinar for health technology developers of medicinal products
In this webinar, Chairs and Co-chairs of the Member State Coordination Group on Health Technology Assessment and its subgroups will explain the process for joint clinical assessments and joint scientific consultations. The webinar is targeted...





